| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000004146 |
| Receipt No. | R000004974 |
| Official scientific title of the study | The clinical effect of Silodosin for lower urinary tract symptoms after permanent prostate brachytherapy |
| Date of disclosure of the study information | 2010/10/01 |
| Last modified on | 2016/09/13 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | The clinical effect of Silodosin for lower urinary tract symptoms after permanent prostate brachytherapy | |
| Title of the study (Brief title) | The effect of Silodosin for LUTS after permanent prostate brachytherapy | |
| Region |
|
|
| Condition | ||
| Condition | Prostate cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The objective of this study is to evaluate the efficacy of silodosin for LUTS after prostate brachytherapy by comparing outcomes assessed by IPSS, QOL, OABSS, IIEF-5 scores. Patients are randomized into two group according to dosage of silodosin (4mg / day vs 8mg / day). |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | IPSS score, QOL score, OABSS score, IIEF-5 score, SF-8 score, EPIC score, Uroflowmetry Qmax |
| Key secondary outcomes | safety |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | Numbered container method |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Silodocin 8mg/day | |
| Interventions/Control_2 | Silodocin 4mg/day | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | Pathologically proven prostate cancer.
Patient who underwent prostate brachytherapy or prostate brachyterapy in combination with external beam radiation therapy. Written informed consent can be obtained. |
|||
| Key exclusion criteria | Patient with allergy against Silodocin.
Patient with neurogenic bladder, bladder neck constructure, urethral stenosis, vesical stone, or large bladder diverticulum. Patient with active urinary tract infection. Patient with severe renal dysfunction. Patient with severe liver disease. Patient who is considered to be inapropriate for this study by physisian. |
|||
| Target sample size | 60 | |||
| Research contact person | |
| Name of lead principal investigator | Masato Fujisawa |
| Organization | Kobe University Graduate School of Medicine |
| Division name | Division of Urology |
| Address | 7-5-2, Kusunoki-cho, Chuo-ku, Kobe, Japan |
| TEL | 078-382-6155 |
| Public contact | |
| Name of contact person | Mototsugu Muramaki |
| Organization | Kobe University Graduate School of Medicine |
| Division name | Division of Urology |
| Address | 7-5-2, Kusunoki-cho, Chuo-ku, Kobe, Japan |
| TEL | 078-382-6155 |
| Homepage URL | |
| muramaki@med.kobe-u.ac.jp | |
| Sponsor | |
| Institute | Kobe University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kobe University Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 神戸大学病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000004974 |